Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway.
Open Access
- 1 July 1994
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 94 (1) , 376-383
- https://doi.org/10.1172/jci117332
Abstract
The trefoil peptides, a recently recognized family of protease-resistant peptides, expressed in a regional specific pattern throughout the normal gastrointestinal tract. Although these peptides have been hypothesized to act as growth factors, their functional properties are largely unknown. Addition of recombinant trefoil peptides human spasmolytic polypeptide (HSP), rat and human intestinal trefoil factor (RITF and HITF) to subconfluent nontransformed rat intestinal epithelial cell lines (IEC-6 and IEC-17), human colon cancer-derived cell lines (HT-29 and CaCO2) or nontransformed fibroblasts (NRK and BHK) had no significant effect on proliferation. However addition of the trefoil peptides to wounded monolayers of confluent IEC-6 cells in an in vitro model of epithelial restitution resulted in a 3-6-fold increase in the rate of epithelial migration into the wound. Stimulation of restitution by the trefoil peptide HSP was enhanced in a cooperative fashion by the addition of mucin glycoproteins purified from the colon or small intestine of either rat or man, achieving up to a 15-fold enhancement in restitution. No synergistic effect was observed by the addition of nonmucin glycoproteins. In contrast to cytokine stimulation of intestinal epithelial cell restitution which is mediated through enhanced TGF beta bioactivity, trefoil peptide, and trefoil peptide-mucin glycoprotein stimulation of restitution was not associated with alteration in concentrations of bioactive TGF-beta and was not affected by the presence of immunoneutralizing anti-TGF beta antiserum. Collectively, these findings suggest that the trefoil peptides which are secreted onto the lumenal surface of the gastrointestinal tract may act in conjunction with the mucin glycoprotein products of goblet cells to promote reestablishment of mucosal integrity after injury through mechanisms distinct from those which may act at the basolateral pole of the epithelium.Keywords
This publication has 43 references indexed in Scilit:
- The P-domain or trefoil motif: a role in renewal and pathology of mucous epithelia?Trends in Biochemical Sciences, 1993
- Purification and characterization of the trefoil peptide human spasmolytic polypeptide (hSP) produced in yeastFEBS Letters, 1993
- Human enterocyte (Caco-2) migration is modulated in vitro by extracellular matrix composition and epidermal growth factor.Journal of Clinical Investigation, 1992
- Proton NMR-based determination of the secondary structure of porcine pancreatic spasmolytic polypeptide: one of a new family of "trefoil" motif containing cell growth factorsBiochemistry, 1992
- The Transforming Growth Factor-beta FamilyAnnual Review of Cell Biology, 1990
- Expression of spasmolysin (FIM-A.1): An integumentary mucin from Xenopus laevisExperimental Cell Research, 1990
- A new family of growth factor‐like peptides ‘Trefoil’ disulphide loop structures as a common feature in breast cancer associated peptide (pS2), pancreatic spasmolytic polypeptide (PSP), and frog skin peptides (spasmolysins)FEBS Letters, 1989
- Growth stimulatory effect of pancreatic spasmolytic polypeptide on cultured colon and breast tumor cellsFEBS Letters, 1989
- Effects of growth factors on an intestinal epithelial cell line: Transforming growth factor β inhibits proliferation and stimulates differentiationBiochemical and Biophysical Research Communications, 1987
- β-Transforming Growth Factor is stored in human blood platelets as a latent high molecular weight complexBiochemical and Biophysical Research Communications, 1986